본문 바로가기

전체 글

 (819)
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) Market Size of CAR T-Cell Therapy for Acute Lymphoblastic Leukemia in the 6MM is expected to be USD 1,315.7 Million in 2030. Among the EU-5 countries, Germany, France, Italy accounts for the highest market size for CAR T-Cell Therapy for Acute Lymphoblastic Leukemia followed by the UK and Spain. Advancement in technology, increased collaboration & acquisition, and competition among biotech & pha..
Chronic Inflammatory Demyelinating Polyneuropathy Market Market Size of Chronic Inflammatory Demyelinating Polyneuropathy in the 7MM was found to be 1194.55 Million in 2017. The total prevalent population of Chronic Inflammatory Demyelinating Polyneuropathy in 7MM countries was estimated to be 44,843 in 2017. Rising Prevalence and Awareness, Advanced Technologies, Increasing R&D Activities are some of the leading factors expected to drive the Chronic ..
Chemotherapy Induced Febrile Neutropenia Market Neutropenia is one of the most severe hematologic toxicities of cancer chemotherapy and often limits the doses of chemotherapy tolerated by the patients. It is a condition that results in a low neutrophil count in the blood, thus rendering the patient susceptible to infections from pathogens, ultimately leading to fever – in the case known as Chemotherapy-Induced Febrile Neutropenia (CIFN). Febr..
Chronic Lower Back Pain (CLBP) Market The market size of Chronic Lower Back Pain in the 7MM is expected to grow at a CAGR of 3.55% for the study period, 2017– 2030. Among the 7MM countries, the United States had the highest market size of Chronic lower back pain (CLBP) in 2017, which accounts for approximately 62.18% of the total market. In 2017, the total Prevalent Population of Chronic lower back pain (CLBP) in the 7MM was found t..
Hemophilia A Market The market size of Hemophilia A was found to be USD 6,266 Million in 2017. The total diagnosed and treated prevalent population of Hemophilia A was found to be 38,212 in 2017 (in the 7MM). The popularity of Gene Therapy, Development of Novel Treatments with an extended half-life, and Increased Focus on Prophylactic Treatment are some of the leading factors expected to drive the Hemophilia A mark..
Neoantigen based Personalized Cancer Therapeutic Vaccines Market Neoantigen-based Personalized Cancer therapeutic Vaccines are one way to utilize the body’s immune system to fight cancer. Neoantigens are non-autologous proteins which are specific to individuals and are a result of non-synonymous mutations in the tumor cell genome. Bioinformatics-technological advancements, improved diagnosis, and a strong pipeline are some of the factors contributing to the a..
CAR-T Cell Therapy for Non-Hodgkin’s Lymphoma Market Size of CAR T Cell Therapy for Non-Hodgkin's Lymphoma in the 6MM is anticipated to be USD 2796.2 Million in 2030. Diffuse large B-cell Lymphoma (DLBCL) is the most common type of NHL, accounting for about 22% of newly diagnosed cases of B-cell NHL in the united states. Advancements in technology, Increased collaborations & acquisitions and Competition among biotech & pharma giants are som..
Retinitis Pigmentosa Market The market size of Retinitis Pigmentosa in the 7MM was USD 237.27 million (in 2017). Among the 7MM countries, the United States had the highest market size of 56.40% of the total market in 2017. According to DelveInsight, the total diagnosed prevalent population of Retinitis Pigmentosa (RP) in the 7MM was 253,420 in 2017. These cases are expected to increase with a significant CAGR during the st..

티스토리툴바